How to Order from LillyDirect: UK and US Guide

How to order from LillyDirect depends on whether you are in the United States or the United Kingdom, as the two services operate very differently. LillyDirect is a direct-to-patient service from Eli Lilly and Company that launched in the US in 2024 and became available in the UK around June 2026. In the US, it connects patients with telehealth providers and affiliated pharmacies. In the UK, it functions solely as a dispensing and delivery service for privately prescribed Mounjaro (tirzepatide). This guide explains how each service works, eligibility requirements, costs, and how UK patients can access Lilly medicines safely through regulated channels.

What Is LillyDirect and Is It Available in the UK?

LillyDirect is available in the UK from around June 2026, but operates only as a dispensing and delivery service for privately prescribed Mounjaro — UK law prohibits manufacturers from selling prescription-only medicines directly to patients.

LillyDirect is a direct-to-patient pharmacy and healthcare service from Eli Lilly and Company. It launched in the United States in 2024 to help patients access Lilly medicines (including tirzepatide and insulin products) more conveniently, and in the US it also offers certain medicines on a self-pay basis. Since around 25 June 2026, LillyDirect is also available in the United Kingdom, but the UK service is quite different from the US one, so older articles describing it as US-only are now out of date.

In the US, LillyDirect connects patients with telehealth providers and affiliated pharmacies and can offer self-pay pricing. In the UK, a manufacturer cannot lawfully sell prescription-only medicines directly to patients, so LillyDirect operates only as a dispensing and delivery service: a UK-regulated healthcare provider must first issue a private prescription for Mounjaro, and Lilly's UK dispensing partners (at launch, Pharmacy2U and Onescript) then fulfil and deliver it. Lilly plays no role in the clinical decision and does not set a self-pay price.

Whichever country you are in, the sale or supply of prescription-only medicines (POMs) is lawful only through appropriately registered channels. In the UK, that means a UK-registered prescriber and a pharmacy registered with the General Pharmaceutical Council (GPhC), as set out in the Human Medicines Regulations 2012. Purchasing POMs from overseas websites or unregistered suppliers, including any unofficial route claiming to give UK access to the US LillyDirect self-pay service, is not a lawful way to obtain medicines in the UK. The MHRA advises strongly against buying medicines from unregistered online sources, as products may be counterfeit, substandard, or poorly stored.^[3][4] You can verify an online pharmacy using the GPhC online register (pharmacyregulation.org).

In the UK, Eli Lilly's medicines (including Mounjaro (tirzepatide) and various insulin formulations) are available through legitimate NHS and private prescribing routes, regulated by the MHRA and informed by NICE guidance. This article explains how LillyDirect works in the US, how the new UK service works, and how UK patients can access Lilly medicines safely and legally.

How to Place an Order Through LillyDirect

In the UK, you cannot order directly from LillyDirect; you must first obtain a private prescription from a UK-regulated prescriber, after which Lilly's dispensing partners (Pharmacy2U or Onescript) can fulfil and deliver it.

How you 'order' from LillyDirect depends entirely on which country you are in, because the two services work differently.

In the US (self-pay or telehealth model): LillyDirect is accessible via lillydirect.com, which is geographically restricted to US-based users. The typical process is:

• Create an account with a valid US address, date of birth, and contact details.

• Select a medication or service, such as a weight-management or diabetes treatment.

• Connect with a telehealth provider: LillyDirect partners with independent telehealth companies who consult and, where appropriate, issue prescriptions.

• Pharmacy fulfilment: once a prescription is issued, it is sent to an affiliated pharmacy for dispensing and home delivery.

Even in the US, LillyDirect does not itself prescribe; it connects patients with independent, licensed healthcare providers, and clinical decisions remain with those professionals.

In the UK (dispensing and delivery model): you do not 'order' Mounjaro directly from LillyDirect. Instead:

• You first have a consultation with a UK-regulated healthcare provider (an online clinic or prescriber) who assesses whether tirzepatide is appropriate.

• If it is, they issue a private prescription for Mounjaro.

• That prescription can then be dispensed and delivered by one of Lilly's UK dispensing partners (at launch, Pharmacy2U or Onescript), or by another GPhC-registered pharmacy.

The UK service therefore sits at the end of the process (dispensing and delivery), not the start. It is not a shortcut around a clinical assessment, and it does not offer the US self-pay pricing. Any third-party service claiming to give UK patients direct access to US LillyDirect self-pay medicines should be treated with extreme caution, and the MHRA continues to advise against buying prescription medicines from unregulated online sources (see gov.uk/guidance/buying-medicines-online).

Eligibility, Prescriptions and Safety Requirements

A valid prescription following a clinical assessment is required in both countries; in the UK, Mounjaro is licensed for adults with type 2 diabetes or a BMI of at least 30 kg/m² (or ≥27 kg/m² with a weight-related comorbidity).

Both the US and UK services require a valid prescription issued after an appropriate clinical assessment, because prescription-only medicines should never be supplied without one. In the US, LillyDirect's telehealth partners assess medical suitability (including BMI, comorbidities, and contraindications) before a US-licensed provider issues a prescription. In the UK, a UK-regulated prescriber performs the same gatekeeping role before any Mounjaro prescription is issued, and only then can Lilly's dispensing partners deliver it.

Tirzepatide, marketed as Mounjaro in the UK, is a dual GLP-1 and GIP receptor agonist licensed for the management of type 2 diabetes and for weight management in eligible adults.^[5][6] The following safety information reflects the UK Summary of Product Characteristics (SmPC) for Mounjaro, as authorised by the MHRA.

Contraindications (UK SmPC): the only contraindication is hypersensitivity to tirzepatide or any excipient. Mounjaro should not be used in pregnancy or while breastfeeding.

Important precautions and safety counselling:

• Pancreatitis: stop treatment and seek urgent medical attention for severe or persistent abdominal pain that may radiate to the back, with or without vomiting, as this may signal acute pancreatitis.

• Hypoglycaemia: when used with insulin or a sulfonylurea (for example gliclazide), the risk of hypoglycaemia increases; dose reduction of the insulin or sulfonylurea may be required. Counsel patients on recognising and managing hypoglycaemia.

• Gallbladder disease: cholelithiasis (gallstones) and cholecystitis have been reported. Seek medical advice for right upper abdominal pain, fever, or jaundice.

• Dehydration and renal impairment: gastrointestinal side effects (nausea, vomiting, diarrhoea) can cause dehydration and worsen renal function; maintain adequate fluid intake, particularly during dose escalation.

• Oral contraceptives: tirzepatide may reduce the exposure of oral contraceptives. Women using oral hormonal contraceptives should switch to a non-oral method, or add a barrier method, for at least four weeks after starting tirzepatide and for four weeks after each dose increase, in line with the UK SmPC.

• Pregnancy and breastfeeding: do not use during pregnancy or breastfeeding; women of childbearing potential should use effective contraception during treatment.

• Thyroid history (US vs UK difference): unlike the US prescribing information for Zepbound and Mounjaro, a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) is not listed as a contraindication in the UK SmPC. Patients with thyroid concerns should still discuss them with their prescriber.

Common adverse effects include nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation. Patients should be counselled on these by a qualified prescriber before starting.

Reporting side effects: report any suspected adverse reactions to the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk. For full prescribing information, refer to the Mounjaro UK SmPC via the Electronic Medicines Compendium (EMC) at medicines.org.uk, and the NHS Medicines A to Z entry for tirzepatide (Mounjaro).

Costs, Delivery and What to Expect After Ordering

The UK LillyDirect service adds a delivery option but not US-style self-pay pricing; private Mounjaro costs are set by the prescribing service and dispensing pharmacy, and NHS prescriptions are subject to standard charges or exemptions.

For US patients, one appeal of LillyDirect is cost transparency and potential savings. Lilly runs programmes such as the Lilly Insulin Value Program, which caps monthly insulin costs for eligible patients, and self-pay pricing for medicines including Zepbound. The actual cost depends on insurance coverage, the medicine, and the pharmacy. These US programmes are for US patients only.

In the UK, the position is different. The new UK LillyDirect service added a delivery option, not a discount: because Lilly cannot sell POMs directly to UK patients, it does not offer US-style self-pay pricing here, and the cost of a private Mounjaro prescription is still set by the prescribing service and the dispensing pharmacy. NHS prescriptions, where a patient is eligible, are subject to the standard NHS prescription charge (or are free where an exemption applies).

Delivery through LillyDirect-affiliated pharmacies (in both countries) is by tracked service, with cold-chain packaging where required, which matters for products such as insulin (typically stored at 2 to 8 degrees Celsius before first use). After a prescription is issued, patients can generally expect confirmation of the prescription review, pharmacy processing, tracked delivery to the registered address, and ongoing support for refills and queries.

A clear warning on importing from abroad: purchasing prescription medicines from unregistered overseas websites, including any service claiming to ship US LillyDirect products to the UK, is not a lawful or safe way to obtain medicines here. The MHRA warns that such medicines may be counterfeit, contaminated, or incorrectly stored, and items may be seized at the UK border. There is no guarantee of product authenticity, appropriate cold-chain storage in transit, or clinical follow-up, all of which are critical for injectable medicines such as tirzepatide. Now that Mounjaro is available through regulated UK routes (including UK LillyDirect delivery), there is no need to take these risks. For guidance, see MHRA 'Buying medicines online' (gov.uk/guidance/buying-medicines-online) and GOV.UK guidance on bringing medicines into the UK.

UK Alternatives for Accessing Lilly Medications Safely

UK patients can access Mounjaro via NHS prescribing (NICE TA924 for type 2 diabetes; TA1026 for weight management) or regulated private clinics registered with the CQC, using GPhC-registered pharmacies.

UK patients have several safe, regulated routes to access Lilly medicines, all of which provide appropriate clinical oversight, product authenticity, and ongoing monitoring.

Through the NHS: Mounjaro (tirzepatide) is available on the NHS for eligible patients with type 2 diabetes, in line with NICE technology appraisal TA924.^[16][17] For weight management, NICE TA1026 recommends tirzepatide within specialist services, phased in over several years, so NHS weight-management access is currently limited and prioritised by clinical need. Speak with your GP or specialist about whether you meet current criteria. NHS prescriptions are dispensed through GPhC-registered UK pharmacies. Be aware that NHS England has issued guidance on GLP-1 supply and prioritisation, which can affect availability.

Through regulated private prescribing: Mounjaro holds MHRA authorisation for weight management, and for private prescribing the relevant thresholds are the licence thresholds in the SmPC: a BMI of at least 30 kg/m², or at least 27 kg/m² (and below 30) with at least one weight-related comorbidity. These are broader than the NHS funding thresholds under NICE TA1026 (a BMI of at least 35 kg/m² with a comorbidity, phased in), so it is worth being clear which set applies to your situation and confirming current criteria with your prescriber.

Private clinics and online services registered with the Care Quality Commission (CQC) and using GPhC-registered pharmacies can legally prescribe and dispense Mounjaro. Since June 2026, delivery of a private Mounjaro prescription can also be arranged through Eli Lilly's own LillyDirect dispensing partners (Pharmacy2U and Onescript), though many other regulated pharmacies dispense it too.

Verifying a UK provider, what to check:

• CQC registration of the prescribing service (cqc.org.uk)

• GPhC registration of the dispensing pharmacy (pharmacyregulation.org)

• That the prescriber is registered with the relevant body (GMC for doctors, NMC for nurse prescribers, GPhC for pharmacist prescribers)

• That a full medical consultation is conducted before any prescription is issued

• That ongoing monitoring and follow-up are included

Warning, unlicensed and compounded products: Unlicensed or 'compounded' tirzepatide products are not permitted for supply in the UK.^[19][3] Only MHRA-authorised Mounjaro, supplied through a GPhC-registered pharmacy on a valid UK prescription, should be used. Do not buy tirzepatide from unverified online sources.

When to contact your GP: If you are considering tirzepatide or another Lilly medicine for diabetes or weight management, your GP is a sensible first point of contact. They can assess suitability, refer you to specialist services where appropriate, and help monitor your overall health throughout treatment.

In summary, LillyDirect now operates in the UK, but only as a dispensing and delivery service for privately-prescribed Mounjaro; it does not replace a clinical assessment. Safe, effective routes to Lilly medicines exist through the NHS and regulated private channels, and patients should use only MHRA-authorised products via CQC-registered services and GPhC-registered pharmacies, and avoid buying prescription medicines from unverified or overseas sources.

Scientific References

1. Rules for the sale, supply and administration of medicines.
2. Emergency supply of medicines — Human Medicines Regulations 2012.
3. MHRA urges public to avoid illegal online weight-loss medicines.
4. Medicines information.
5. Tirzepatide — BNF.
6. GLP-1 medicines for weight loss and diabetes: what you need to know.
7. Mounjaro (tirzepatide) — EMA product information (SmPC).
8. Mounjaro KwikPen 2.5 mg solution for injection — Summary of Product Characteristics.
9. Mounjaro KwikPen 2.5 mg solution for injection — Patient Information Leaflet.
10. Women on 'skinny jabs' must use effective contraception — MHRA guidance.
11. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4).
12. Long-term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post-hoc analysis of SURPASS-4.
13. Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A meta-analysis.
14. Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diabetes: a systematic review and meta-analysis.
15. Storing and travelling with rapid-acting insulin.
16. Tirzepatide for treating type 2 diabetes (TA924).
17. Tirzepatide for managing overweight and obesity (TA1026).
18. Tirzepatide for managing overweight and obesity — Chapter 1: Recommendations (TA1026).
19. MHRA smashes major illicit weight-loss medicine production facility in record seizure.

Frequently Asked Questions